Jana Špeldová

Most-cited papers

1. Complex analysis of the p53 tumor suppressor in lung carcinoma.

   J. Šmardová, K. Lišková, B. Ravčuková, J. Malčíková +9 more

   2016Oncology Report18 citations Open access

   Semantic Scholar

   Save

2. Pembrolizumab-induced hypothyreosis and subcutaneous bleeding.

   P. Polák, Jana Špeldová, M. Bratová, J. Zavřelová +1 more

   2021Vnitrni lekarstvi2 citations Open access

   Semantic Scholar

   Save

3. Immunodeficiency in the differential diagnosis of interstitial lung diseases.

   M. Doubková, Jana Špeldová, Z. Chovancova

   2019Vnitrni lekarstvi2 citations Open access

   Semantic Scholar

   Save

4. Treatment of patients with non-small cell cancer and EGFR mutations

   J. Skřičková, B. Robešová, Ondřej Venclíček, Bohdan Kadlec +4 more

   2018Onkologie0 citations Open access

   Semantic Scholar

   Save

5. P3.02b-030 Single Institution Experience with EGFR Gene Mutation Analysis and Treatment of EGFR Positive Patients in the Years 2010 to 2015: Topic: EGFR Biomarkers

   Ondřej Venclíček, Petronela Venclíčková, J. Skřičková, Jana Špeldová +5 more

   20170 citations Open access

   Semantic Scholar

   Save

6. Pleurodesis as a Palliative Treatment for Malignant PleuralEffusion

   J. Skřičková, M. Tomíšková, Jana Špeldová, M. Šatánková +4 more

   20130 citations

   Semantic Scholar

   Save

7. Palliative Treatment of Patients with Dysphagia and MalignantStenosis of the Esophagus

   J. Skřičková, Z. Povolná, Jana Špeldová, M. Tomíšková +3 more

   20130 citations

   Semantic Scholar

   Save